Significance of ER–Src axis in hormonal therapy resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Significance of ER–Src axis in hormonal therapy resistance

Published:2010-12-24 Issue:2 Volume:130 Page:377-385
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Vallabhaneni Sreeram,Nair Binoj C.,Cortez Valerie,Challa Rambabu,Chakravarty Dimple,Tekmal Rajeshwar Rao,Vadlamudi Ratna K.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-010-1312-2.pdf

Reference40 articles.

1. Ariazi EA, Ariazi JL, Cordera F, Jordan VC (2006) Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem 6:195–216

2. Lewis-Wambi JS, Jordan VC (2005) Treatment of postmenopausal breast cancer with selective estrogen receptor modulators (SERMs). Breast Dis 24:93–105

3. Leary A, Dowsett M (2006) Combination therapy with aromatase inhibitors: the next era of breast cancer treatment? Br J Cancer 95:661–666

4. Musgrove EA, Sutherland RL (2009) Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9:631–643

5. Gururaj AE, Rayala SK, Vadlamudi RK, Kumar R (2006) Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations. Clin Cancer Res 12:1001s–1007s

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis;Molecular Oncology;2023-11

2. Overview of the therapeutic strategies for ER positive breast cancer;Biochemical Pharmacology;2023-06

3. Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34;Breast Cancer Research and Treatment;2023-05-18

4. Value of Proline, Glutamic Acid, and Leucine-Rich Protein 1 and GATA Binding Protein 3 Expression in Breast Cancer: An Immunohistochemical study;Indian Journal of Surgery;2022-08-03

5. ECM1 is associated with endocrine resistance in ER⁺ breast cancers;Animal Cells and Systems;2022-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3